Anti-Müllerian Hormone (AMH) Programme
Anti-Müllerian Hormone (AMH) Programme
The RIQAS Anti-Mullerian Hormone (AMH) Programme will be run at a frequency of 1 sample per month. The samples will be in a lyophilised format.
- Lyophilised material for enhanced stability
- Submit results and view reports online via RIQAS.Net
- High quality reliable controls – Randox has 30 plus years’ experience as a global manufacturer of QC controls
- Worlds largest EQA scheme ensuring peer groups are maximised
- Monthly reporting to reduce the risk of errors
- Cycle Starts – January 2025
-
-
-
What is AMH used for?
AMH is made in the reproductive tissues of both males and females. The role of AMH and whether levels are normal depend on age and gender.
An AMH test is often used to check a woman’s ability to produce eggs that can be fertilized for pregnancy. A woman’s ovaries can make thousands of eggs during her childbearing years. the number declines as a woman gets older. AMH levels help show how many potential egg cells a woman has left. This is known as the ovarian reserve.
If a woman’s ovarian reserve is high, she may have a better chance of getting pregnant. She may also be able to wait months or years before trying to get pregnant. If the ovarian reserve is low, it may mean a woman will have trouble getting pregnant and show not delay very long before trying to have a baby.
AMH tests may also be used to:
• Predict the start of menopause, a time in a woman’s life when her menstrual periods have stopped, and she can’t
become pregnant anymore. It usually starts when a woman is around 50 years old.
• Find out the reason for early menopause
• Help find out the reason for amenorrhea, the lack of menstruation. It is most often diagnosed in girls who haven’t started
menstruating by the age of 15 and in women who have missed several periods.
• Help diagnose polycystic ovary syndrome (PCOS), a hormonal disorder that is a common cause of female infertility, the
inability to get pregnant
• Check infants with genitals that are not clearly identified as male or female
• Monitor women who have certain types of ovarian cancer
Join the Worlds Largest External Quality Assessment scheme today:
| Description | Frequency | Size | Cat. No | |
|---|---|---|---|---|
| AMH | Monthly | 12 x 1ml | RQ9198 | |
Microbiology (Bacterial Identification) Programme
The RIQAS Microbiology Programme includes the identification of micro-organisms to Gram positive/negative, Genus and Species levels, together with Antimicrobial Susceptibility Testing according to chosen Guidelines.
Available in a bi-monthly format with 3 samples distributed twice per year. Each strain is presented in a lyophilised pellet form within a self-contained tube containing a pre-filled ampoule for reconstitution, therefore helping to avoid cross contamination.
- Lyophilised for enhanced stability
- Multiple registrations allow for comparison between lab staff
- Possible to be used as a training tool for new and current staff
- Samples are manufactured to the highest quality
- Bi-monthly reporting
- Submit results and view reports online via RIQAS.Net
- Cycle Starts – July 2025
-
Join the Worlds Largest External Quality Assessment scheme today:
| Cat. No | Description | Frequency | Parameters | |
|---|---|---|---|---|
| RQ9197 | Microbiology Programme | Bi-monthly, (1 x 12 month cycle) | 2 | |
Parameters
- Antimicrobial Susceptibility Testing
- Strain Identification
Microbiology reports available on RIQAS.net include:
- Bacterial Identification Report
- Bacterial Identification – Historical Performance
- Antimicrobial Susceptibility Testing
- Cefepime
Serum Indices External Quality Assessment
The RIQAS Serum Indices EQA programme is designed for the pre-analytical assessment of Haemolytic, Icteric and Lipemic (HIL) interferences.
Available in a bi-monthly format with the option to report either quantitative or semi-quantitative results for the HIL parameters, this programme also provides an assessment on how these interferences impact on up to 25 routine chemistry parameters. This provides invaluable information on whether a correct judgement is being made to report results.
- Lyophilised for enhanced stability
- Human based serum ensuring commutable sample matrix
- Bi-monthly reporting
- HIL parameters include the option of quantitative or semi-quantitative reporting
- Interpretation of chemistry parameter results
- Submit results and view reports online via RIQAS.Net
- Cycle Starts – October 2025
NOTE: If you require additional Serum Indices EQA material, you can purchase RQ9194/A. This is an additional pack containing 9 x 1ml vials to be used as a supplement to your main RQ9194 Serum Indices programme.
| Cat No | Kit Size | Frequency | Returns | |
|---|---|---|---|---|
| RQ9194 | 2 x (9 x1ml) | Bi-monthly (9 samples per distribution) 2 distributions per cycle | 3 samples bi-monthly | |
Indices Assessment (Quantitative and Semi-Quantitative)
- Haemolysis
- Icteric
- Lipemic
Parameter Assessment (Quantitative)
- ALP
- ALT
- AST
- D. Bilirubin
- T. Bilirubin
- Calcium
- Chloride
- Cholesterol
- CK NAC
- Creatinine
- GGT
- Glucose
- HDL
- Iron
- Lactate
- LDH
- Lipase
- Magnesium
- Phosphate
- Potassium
- Protein Total
- Sodium
- Triglycerides
- Urea
- Uric Acid
Related Products
Cytokine Programme
Introducing our new RIQAS Cytokine programme. The RIQAS Cytokine programme is a comprehensive EQA programme suitable for monitoring the performance of 12 different Cytokines.
- Lyophilised for enhanced stability
- Submit results and view reports online via RIQAS.Net
- All samples should be analysed and results submitted together
- Samples are manufactured to the highest quality ensuring the matrix reacts in same manner as patients sample.
- Cycle Starts October 2025
| Cat No | Kit Size | Parameters | Returns | |
|---|---|---|---|---|
| RQ9195 | 12 x 1ml | 12 | 1 sample per month | |
Parameters
• Epidermal Growth Factor (EGF)*
• Interleukin – 1 alpha (IL-1α)*
• Interleukin – 1 beta (IL-1β)*
• Interleukin – 2 (IL-2)*
• Interleukin – 4 (IL-4)*
• Interleukin – 6 (IL-6)
• Interleukin – 8 (IL-8)*
• Interleukin – 10 (IL-10)*
• Interferon gamma (INF-Y)*
• Monocyte Chemoattractant Protein -1 (MCP-1)*
• Tumour Necrosis Factor alpha (TNF-α)*
• Vascular Endothelial Growth Factor (VEGF)*
*Pilot parameters.
Please note, product availability may vary country to country.
Therapeutic Drugs External Quality Assessment
The RIQAS Therapeutic Drug EQA programme is designed to monitor the performance of an impressive 18 therapeutic drugs. Weighed in values are reported for each parameter.
- Accredited to ISO/IEC 17043
- Lyophilised for enhanced stability
- 100% human serum
- Bi-weekly reporting
- Submit results and view reports online via RIQAS.Net
- Register up to five instruments per programme (volume permitting) at no extra cost for comparative performance assessment
- Weighed in values reported for each parameter
- Cycle Starts – March/September 2025
| Cat No | Kit Size | Frequency | Parameters | |
|---|---|---|---|---|
| RQ9111 | 12 x 5ml | Bi-weekly (2 x 6 monthly cycles) | 18 | |
Parameters
- Amikacin
- Caffeine
- Carbamazepine
- Cyclosporine
- Digoxin
- Ethosuximide
- Gentamicin
- Lithium
- Methotrexate
- Paracetamol
- Phenobarbital
- Phenytoin
- Primidone
- Salicylic Acid
- Theophylline
- Tobramycin
- Valproic Acid
- Vancomycin
Please note, product availability may vary country to country.
Related Products
Specific Protein External Quality Assessment
The RIQAS Specific Protein EQA programme is designed to monitor the performance of up to 26 serum proteins including CRP, ASO, RF, Complement Proteins and Immunoglobulins. Four programme options are available to help reduce waste and costs.
- Accredited to ISO/IEC 17043
- Liquid ready-to-use
- 100% human serum
- Flexible options available with bi-weekly or monthly reporting
- Submit results and view reports online via RIQAS.Net
- Register up to five instruments per programme (volume permitting) at no extra cost for comparative performance assessment
Cycles Start:
RQ9114 (Bi-Weekly) – March/September 2025
RQ9187 (Monthly) – March 2025
| Cat No | Kit Size | Frequency | Parameters | |
|---|---|---|---|---|
| RQ9114 | 12 x 3ml | Bi-weekly (2 x 6 monthly cycles) | 26 analytes | |
| RQ9187 | 12 x 1ml | Monthly (1 x 12 month cycle) | 26 analytes | |
Parameters
- AFP
- Albumin
- Alpha-1-acid glycoprotein
- Alpha-1-antitrypsin
- Alpha-2-macroglobulin
- Anti Streptolysin O
- Antithrombin III
- Beta-2-microglobulin
- Ceruloplasmin
- Complement, C3
- Complement, C4
- C-Reactive Protein
- Ferritin
- Haptoglobin
- Immunoglobulin A
- Immunoglobulin E
- Immunoglobulin G
- Immunoglobulin M
- Free Kappa Light Chain
- Total Kappa Light Chain
- Free Lambda Light Chain
- Total Lambda Light Chain
- Prealbumin (Transthyretin)
- Retinol Binding Protein
- Rheumatoid Factor
- Transferrin
Please note, product availability may vary country to country.
Related Products
Lipids External Quality Assessment
The RIQAS Lipid EQA programme is designed to monitor the performance of up to 7 lipid parameters. Two flexible and cost effective programme options are available.
- Accredited to ISO/IEC 17043
- Lyophilised for enhanced stability
- 100% human serum
- Bi-weekly reporting
- Choose from 3 or all 7 parameter options
- Submit results and view reports online via RIQAS.Net
- Register up to five instruments per programme (volume permitting) at no extra cost for comparative performance assessment
- Cycles Start – January/July 2025
| Cat No | Kit Size | Frequency | Parameters | |
|---|---|---|---|---|
| RQ9126/a | 12 x 3ml | Bi-weekly (2 x 6 monthly cycles) | 3 parameters (choose from 7) | |
| RQ9126/b | 12 x 3ml | Bi-weekly (2 x 6 monthly cycles) | All 7 parameters | |
Parameters
- Apolipoprotein A1
- LDL-Cholesterol
- Triglycerides
- Apolipoprotein B
- Lipoprotein (a)
- HDL-Cholesterol
- Total Cholesterol
Please note, product availability may vary country to country.
Related Products
Immunoassay External Quality Assessment
Powered by BiozThe RIQAS Immunoassay EQA programme is designed to monitor the performance of up to 51 immunoassay parameters including therapeutic drugs; hormones and tumour markers. Four flexible and cost effective programme options are available.
- Accredited to ISO/IEC 17043
- Lyophilised for enhanced stability
- 100% human serum
- Bi-weekly reporting
- Choose 4 parameters, 13 parameters or all 51 parameters
- Submit results and view reports online via RIQAS.Net
- Register up to five instruments per programme (volume permitting) at no extra cost for comparative performance assessment
Cycles Start:
RQ9125 (Bi-Weekly) – January/July 2025
RQ9130 (Monthly) – January 2025
| Cat No | Kit Size | Frequency | Parameters | |
|---|---|---|---|---|
| RQ9125/a | 12 x 5ml | Bi-weekly (2 x 6 month cycle) | 4 parameters only (Choose from 51) | |
| RQ9125/b | 12 x 5ml | Bi-weekly (2 x 6 month cycle) | 13 parameters only (Choose from 51) | |
| RQ9125/c | 12 x 5ml | Bi-weekly (2 x 6 month cycle) | All 51 parameters (Bi-weekly reporting) | |
| RQ9130 | 12 x 5ml | Monthly (1 x 12 month cycle) | All 51 parameters (Monthly reporting) | |
Parameters
- 1-25-OH-Vitamin D (Pilot)
- 17-OH-progesterone
- 25-OH-Vitamin D
- ACTH
- AFP
- Aldosterone
- Amikacin
- Androstenedione
- B-2-Microglobulin
- CA125
- CA15-3
- CA19-9
- Carbamazepine
- CEA
- Cortisol
- C-peptide
- DHEA, Unconjugated
- DHEA-S
- Digoxin
- Estriol Total (Pilot) *
- Ferritin
- Folate
- Free T3
- Free T4
- Free testosterone (Pilot)
- FSH
- Gentamicin
- GH
- hCG
- IgE
- Insulin
- LH
- Oestradiol
- Paracetamol
- Parathyroid Hormone
- Phenobarbital
- Phenytoin
- Progesterone
- Prolactin
- PSA
- PSA, Free
- Salicylate
- Sex Hormone Binding Globulin (SHBG)
- T3
- T4
- Testosterone
- Theophylline
- Thyroglobulin
- TSH
- Valproic acid
- Vancomycin
- Vitamin B12
*RQ9130 Only
Please note, product availability may vary country to country.
Publications
Related Products
Human Urine External Quality Assessment
The RIQAS Human Urine EQA programme is designed to monitor the performance of 25 routine chemistry assays in urine.
- Accredited to ISO/IEC 17043
- Lyophilised for enhanced stability
- 100% human urine
- Flexible options available with bi-weekly or monthly reporting
- 10ml samples provided
- Submit results and view reports online via RIQAS.Net
- Register up to five instruments per programme (volume permitting) at no extra cost for comparative performance assessment
Cycles Start:
RQ9115 (Bi-Weekly) – January 2025
RQ9185 (Monthly) – July 2025
| Cat No | Kit Size | Frequency | Parameters | |
|---|---|---|---|---|
| RQ9115 | 24 x 10ml | Bi-Weekly (2 x 6 month cycles) | 25 | |
| RQ9185 | 12 x 10ml | Monthly (1 x 12 month cycle) | 25 | |
Parameters
- Albumin / Microalbumin
- Albumin/Creatinine Ration
- Amylase
- Calcium
- Chloride
- Copper
- Cortisol
- Creatinine
- Dopamine
- Epinephrine
- Glucose
- Magnesium
- Metanephrine
- Norepinephrine
- Normetanephrine
- Osmolality
- Oxalate
- Phosphate, inorganic
- Potassium
- Protein, total
- Sodium
- Urea
- Uric acid
- VMA
- 5-HIAA
Please note, product availability may vary country to country.
Related Products
Haematology External Quality Assessment
The RIQAS Haematology EQA programme is designed to monitor the performance of 11 haematology parameters. All samples are supplied liquid ready-to-use in primary tubes for ease-of-use and convenience.
- Accredited to ISO/IEC 17043:2010
- Liquid ready-to-use
- 100% whole blood
- Flexible options available with bi-weekly and monthly reporting
- Register up to five instruments per programme (volume permitting) at no extra cost for comparative performance assessment
- Samples provided in primary tubes with penetrable septums
Cycles Start:
RQ9118 (Bi-Weekly) – March/September 2025
RQ9140 (Monthly) – January 2025
| Cat No | Kit Size | Frequency | Parameters | |
|---|---|---|---|---|
| RQ9118 | 6 x 2ml (primary tubes) | Bi-weekly (2 x 6 monthly cycles) | 11 | |
| RQ9140 | 12 x 2 ml | Monthly (1 x 12 month cycle) | 11 | |
Parameters
- Haemoglobin (Hb)
- Mean Cell Volume (MCV)
- Mean Cell Haemoglobin Concentration (MCHC)
- Red Blood Cell Count (RBC)
- Mean Platelet Volume
- Plateletcrit
- Haematocrit (HCT)
- Mean Cell Haemoglobin (MCH)
- Platelets (PLT)
- Total White Blood Cell Count (WBC)
- Red Cell Dist. Width
Please note, product availability may vary country to country.